Ah Equity Partners Bio Ii, L.L.C. Invitae Corp Transaction History
Ah Equity Partners Bio Ii, L.L.C.
- $144 Million
- Q3 2022
A detailed history of Ah Equity Partners Bio Ii, L.L.C. transactions in Invitae Corp stock. As of the latest transaction made, Ah Equity Partners Bio Ii, L.L.C. holds 1,276,541 shares of NVTA stock, worth $0. This represents 2.19% of its overall portfolio holdings.
Number of Shares
1,276,541
Previous 1,170,127
9.09%
Holding current value
$0
Previous $2.86 Million
9.98%
% of portfolio
2.19%
Previous 2.0%
Shares
2 transactions
Others Institutions Holding NVTA
# of Institutions
56Shares Held
7.66MCall Options Held
0Put Options Held
0-
State Of Wyoming Cheyenne, WY3.65MShares$00.01% of portfolio
-
Goldman Sachs Group Inc New York, NY902KShares$00.0% of portfolio
-
Green Alpha Advisors, LLC450KShares$00.0% of portfolio
-
Alphabet Inc. Mountain View, CA236KShares$00.0% of portfolio
-
Longitude (Cayman) Ltd. Grand Cayman, E9215KShares$00.0% of portfolio
About Invitae Corp
- Ticker NVTA
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 235,266,000
- Description
- Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...